Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6.60 INR
Change Today -0.34 / -4.90%
Volume 50.0
ALIF On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

aasda lifecare ltd (ALIF) Snapshot

Open
6.60
Previous Close
6.94
Day High
6.60
Day Low
6.60
52 Week High
09/1/14 - 10.90
52 Week Low
08/4/14 - 5.73
Market Cap
69.7M
Average Volume 10 Days
5.5
EPS TTM
24.69
Shares Outstanding
10.6M
EX-Date
09/22/10
P/E TM
0.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for AASDA LIFECARE LTD (ALIF)

Related News

No related news articles were found.

aasda lifecare ltd (ALIF) Related Businessweek News

No Related Businessweek News Found

aasda lifecare ltd (ALIF) Details

Finaventure Capital Limited operates as an investment company in India. It primarily invests in strategic investments in DR. Datsons Labs Limited. The company through its interests in Aanjaneya Lifecare Limited, engages in pharmaceutical business. It also focuses on investing in operating companies in non competing sectors. The company was formerly known as Aasda Life Care Limited and changed its name to Finaventure Capital Limited in June 2011. Finaventure Capital Limited was incorporated in 1985 and is based in Raigad District, India.

Founded in 1985

aasda lifecare ltd (ALIF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

aasda lifecare ltd (ALIF) Key Developments

Finaventure Capital Limited Announces the Resignation of Rajendra Kamat as Non Executive Chairman

Finaventure Capital Ltd. announced that change in designation of Mr. Rajendra Kamat, Non Executive Chairman of the company vacated the post as the Non Executive Chairman but will continue as a Vice Chairman and Managing Director of the company with effect from June 16, 2015.

Finaventure Capital Limited, Board Meeting, May 30, 2015

Finaventure Capital Limited, Board Meeting, May 30, 2015. Agenda: To approve the audited financial results for the financial year ended March 31, 2015.

Finaventure Capital Ltd Announces Board Changes

Finaventure Capital Ltd. announced that the board of directors of the company at its meeting held on May 11, 2015, has decided to appoint Mr. Dinesh Surana, as the additional director of the company with effect from May 11, 2015. The meeting also approved the resignation of Mr. Mahesh Vaidya, as the vice chairman & managing director of the company with effect from May 11, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALIF:IN 6.60 INR -0.34

ALIF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALIF.
View Industry Companies
 

Industry Analysis

ALIF

Industry Average

Valuation ALIF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AASDA LIFECARE LTD, please visit www.finacaps.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.